Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cancer Medicine
|
March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients
Hongnan Mo, Xuezhi Hao, Yutao Liu, et al.
Chronic Diseases and Translational Medicine
|
September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
Hongnan Mo, Peng Liu, Yan Qin, et al.
Nature Communications
|
February 2, 2026
Paclitaxel drives TREM2<sup>+</sup> macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel
Yuqi Xing, Ruiqi Zhong, Qianchen Li, et al.
Breast (Edinburgh, Scotland)
|
April 9, 2025
The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study
Xuenan Peng, Bo Lan, Jiayu Wang, et al.
Frontiers in Cardiovascular Medicine
|
November 16, 2020
Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients
Binliang Liu, Junying Xie, Xiaoying Sun, et al.
Frontiers in Oncology
|
May 28, 2021
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
Shaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2022
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
Yiqun Li, Hongnan Mo, Xiuwen Guan, et al.
Breast (Edinburgh, Scotland)
|
August 25, 2020
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China
Shaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Frontiers in Oncology
|
February 3, 2022
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo, et al.
BMJ Open
|
June 3, 2019
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China
Shiyu Jiang, Peng Liu, Sheng Yang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cancer Medicine
|
March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients
Hongnan Mo, Xuezhi Hao, Yutao Liu, et al.
Chronic Diseases and Translational Medicine
|
September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
Hongnan Mo, Peng Liu, Yan Qin, et al.
Nature Communications
|
February 2, 2026
Paclitaxel drives TREM2<sup>+</sup> macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel
Yuqi Xing, Ruiqi Zhong, Qianchen Li, et al.
Breast (Edinburgh, Scotland)
|
April 9, 2025
The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study
Xuenan Peng, Bo Lan, Jiayu Wang, et al.
Frontiers in Cardiovascular Medicine
|
November 16, 2020
Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients
Binliang Liu, Junying Xie, Xiaoying Sun, et al.
Frontiers in Oncology
|
May 28, 2021
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
Shaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2022
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
Yiqun Li, Hongnan Mo, Xiuwen Guan, et al.
Breast (Edinburgh, Scotland)
|
August 25, 2020
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China
Shaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Frontiers in Oncology
|
February 3, 2022
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo, et al.
BMJ Open
|
June 3, 2019
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China
Shiyu Jiang, Peng Liu, Sheng Yang, et al.
Page
of 6